Simplex Trading’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History

Simplex Trading’s Portfolio DRNA Stock Details DRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,759	Closed	-$50K	–	11914
2021 Q3	$66K	Hold	1,759	–	–	﹤0.01%	7179
2021 Q2	$65K	Buy	1,759 +1,482	+535%	+$45.4K	﹤0.01%	7326
2021 Q1	$7K	Buy	+277	New	+$7.08K	﹤0.01%	8115
2020 Q4	–	Sell	-35,356	Closed	-$779K	–	9391
2020 Q3	$636K	Buy	+35,356	New	+$732K	﹤0.01%	2742
2020 Q1	–	Sell	-1,992	Closed	-$38.7K	–	8558
2019 Q4	$43K	Buy	1,992 +1,901	+2,089%	+$38.3K	﹤0.01%	5344
2019 Q3	$1K	Buy	+91	New	+$1.3K	﹤0.01%	7118
2019 Q2	–	Sell	-58	Closed	–	–	8131
2019 Q1	$0	Sell	58 -48	-45%	-$552	﹤0.01%	8169
2018 Q4	$1K	Buy	+106	New	+$1.39K	﹤0.01%	6842
2018 Q3	–	Sell	-10,226	Closed	-$125K	–	8347
2018 Q2	$125K	Buy	+10,226	New	+$128K	﹤0.01%	4032

Other funds holding DRNA

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

Simplex Trading's DRNA Position: Q4 2021 in Review

Simplex Trading sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 1,759 shares — an estimated $50K sold.

Simplex Trading first reported a position in DRNA in Q2 2018 and held it in 9 quarters. The position peaked at $636K in Q3 2020. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.

Simplex Trading reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Simplex Trading sold 1,759 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $50K.
Simplex Trading first reported a position in Dicerna Pharmaceuticals, Inc. in Q2 2018 and held it in 9 quarters.
Simplex Trading's Dicerna Pharmaceuticals, Inc. position peaked at $636K in Q3 2020.
1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.

Based on Simplex Trading's 13F filing for Q4 2021, filed 4 Feb 2022.